Αναζήτηση αυτού του ιστολογίου

Παρασκευή 13 Οκτωβρίου 2017

Co-inhibitory profile and cytotoxicity of CD57+PD-1- T-cells in end stage renal disease patients

Summary

Blockade of the CD80/86-CD28 pathway by belatacept after kidney transplantation is associated with an increased risk of rejection as compared with standard, calcineurin inhibitor (CNI)-based therapy. CD28- T-cells, which express CD57, are not susceptible to belatacept treatment. High number of CD4+CD57+PD-1- T-cells pre transplantation have been associated with a higher chance of rejection, although conflicting data have been reported. To investigate the working mechanism behind this possible higher chance of rejection, we studied the expression of co-inhibitory molecules (CD223, CD244 and PD-1), proliferative capacity and cytotoxic potential of FACS-sorted CD4+CD57+PD-1- and CD8+CD57+PD-1- T-cells, and their CD57- control populations, after allo antigen stimulation. The effect of belatacept on the cytotoxic capacity of pre-transplantation peripheral blood mononuclear cells from 20 patients who received belatacept post-transplantation was also tested. Expression of co-inhibitory molecule CD223 increased by approximately 10-fold after allogeneic stimulation in all four T-cell subsets. Proliferation and upregulation of CD244 and PD-1 was observed for CD4+CD57-PD-1- T-cells after allogeneic stimulation, but no upregulation of these markers occurred on CD8+ T-cells or CD4+CD57+PD-1- T-cells. However, CD4+CD57+ PD-1- T-cells and, to a lesser extent, CD8+CD57+PD-1- T-cells displayed higher cytotoxicity as indicated by granzyme B expression. Belatacept inhibited the cytotoxic potential of CD4+CD57+PD-1- T-cells (median of inhibition 31%, p<0.01) and CD8+CD57+PD-1- T-cells (median of inhibition 10%, p<0.05).

In conclusion, alloantigen activated CD4+CD57+PD-1- T-cells exhibited a less proliferative but more cytotoxic profile than their CD57- counterparts. Their cytotoxic capacity can be partly inhibited by belatacept and was not associated with development of rejection after kidney transplantation. This article is protected by copyright. All rights reserved.



Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.